Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.42 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.42 |
| ▸ | HTR2C | P28335 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.39 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.39 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.39 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.39 |
| ▸ | HTR2B | P41595 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5101318 | 0.83 | GABRA1 (0.50) | GABRA1GABRB2HTR2CLMNATSHR | |
| SCHEMBL5101317 | 0.83 | GABRA1 (0.50) | GABRA1GABRB2HTR2CLMNATSHR | |
| SCHEMBL382010 | 0.83 | GABRA1 (0.50) | GABRA1GABRB2HTR2CLMNATSHR | |
| SCHEMBL396706 | 0.78 | GABRA1 (0.52) | GABRA1GABRB2HTR2CLMNATSHR | |
| SCHEMBL2544954 | 0.78 | GABRA1 (0.40) | GABRA1GABRB2HTR2CLMNATSHR | |
| SCHEMBL8274478 | 0.76 | GABRA1 (0.56) | GABRA1GABRB2HTR2CLMNATSHR | |
| SCHEMBL5907397 | 0.76 | GABRA1 (0.44) | GABRA1GABRB2HTR2CLMNATSHR | |
| SCHEMBL8274480 | 0.76 | GABRA1 (0.56) | GABRA1GABRB2HTR2CLMNATSHR | |
| SCHEMBL6055133 | 0.76 | GABRA1 (0.56) | GABRA1GABRB2HTR2CLMNATSHR | |
| SCHEMBL588784 | 0.75 | GABRA1 (0.39) | GABRA1GABRB2HTR2CLMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4622169-A | ANTHRAQUINONE OR NAPHTHAQUINONE SUBSTITUTED WITH AMINO GROUP REACTED WITH METAL SALT | THE DOW CHEMICAL COMPANY (US) | 1986-11-11 | — | — | US | claimed |
| US-10370536-B2 | Resin composition, prepreg, resin sheet, metal foil-clad laminate, and printed wiring board | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2019-08-06 | — | — | US | disclosed |
| EP-3115418-B1 | RESIN COMPOSITION, PREPREG, RESIN SHEET, METAL-FOIL-CLAD LAMINATED PLATE, AND PRINTED WIRING BOARD | MITSUBISHI GAS CHEMICAL CO (JP) | 2018-05-23 | — | — | EP | disclosed |
| US-20170158854-A1 | RESIN COMPOSITION, PREPREG, RESIN SHEET, METAL-FOIL-CLAD LAMINATED PLATE, AND PRINTED WIRING BOARD | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2017-06-08 | — | — | US | disclosed |
| EP-3115418-A1 | RESIN COMPOSITION, PREPREG, RESIN SHEET, METAL-FOIL-CLAD LAMINATED PLATE, AND PRINTED WIRING BOARD | Mitsubishi Gas Chemical Company, Inc. (JP) | 2017-01-11 | — | — | EP | disclosed |
| EP-1971611-B1 | ANTI-VIRAL COMPOUNDS | ABBOTT LAB (US) | 2012-10-10 | — | — | EP | disclosed |
| EP-1702919-B1 | NOVEL 2-HETEROARYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVE | MSD KK (JP) | 2012-05-30 | — | — | EP | disclosed |
| EP-2345652-A1 | Antiviral compounds | Abbott Laboratories (US) | 2011-07-20 | — | — | EP | disclosed |
| US-7915411-B2 | Anti-viral compounds | ABBOTT LABORATORIES (US) | 2011-03-29 | — | — | US | disclosed |
| US-7728025-B2 | 2-heteroaryl-substituted benzimidazole derivative | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2010-06-01 | — | — | US | disclosed |
| US-20070197558-A1 | ANTI-VIRAL COMPOUNDS | ABBVIE INC. | 2007-08-23 | — | — | US | disclosed |
| WO-2007081517-A2 | ANTI-VIRAL COMPOUNDS | ABBOTT LABORATORIES (US) | 2007-07-19 | — | — | WO | disclosed |
| EP-1273608-B1 | FLAME-RETARDANT EPOXY RESIN COMPOSITION, MOLDED OBJECT THEREOF, AND ELECTRONIC PART | OTSUKA KAGAKU KK (JP) | 2007-07-04 | — | — | EP | disclosed |
| EP-1702919-A1 | NOVEL 2-HETEROARYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVE | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2006-09-20 | — | — | EP | disclosed |
| EP-1063252-B1 | FLAME-RETARDANT RESIN, COMPOSITION THEREOF, AND PROCESS FOR PRODUCING THE SAME | OTSUKA KAGAKU KK (JP) | 2005-06-08 | — | — | EP | disclosed |
| US-6797750-B2 | Flame-retardant epoxy resin composition, molded article thereof, and electronic part | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 2004-09-28 | — | — | US | disclosed |
| US-6632891-B1 | Obtained by an ester exchange reaction between the flame retardant phosphazene and the polycarbonate or polyester resin | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 2003-10-14 | — | — | US | disclosed |
| US-20030114606-A1 | A phosphazene compound or polyphosphazenes; fireproofing | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 2003-06-19 | — | — | US | disclosed |
| EP-1273608-A1 | FLAME-RETARDANT EPOXY RESIN COMPOSITION, MOLDED OBJECT THEREOF, AND ELECTRONIC PART | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 2003-01-08 | — | — | EP | disclosed |
| EP-1063252-A1 | FLAME-RETARDANT RESIN, COMPOSITION THEREOF, AND PROCESS FOR PRODUCING THE SAME | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 2000-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070197558-A1 | ANTI-VIRAL COMPOUNDS | HAVCR2, MAVS, EIF2AK2 | GABRA1 4202/4885GABRB2 4000/4885HTR2C 4181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.